These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8587164)

  • 61. Analysis of beta-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study Group.
    Chardon H; Farzaneh S; Labia R; Jarlier V; Nicolas MH; Paul G; Poyart C; Sirot D; Sirot J
    J Antimicrob Chemother; 1995 Jul; 36(1):267-9. PubMed ID: 8537279
    [No Abstract]   [Full Text] [Related]  

  • 62. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.
    Zuravleff JJ; Yu VL; Yee RB
    J Lab Clin Med; 1983 Jun; 101(6):896-902. PubMed ID: 6406628
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity.
    Hardin TC; Butler SC; Ross S; Wakeford JH; Jorgensen JH
    Pharmacotherapy; 1994; 14(2):147-52. PubMed ID: 8197032
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections: especially against beta-lactamase producing strains].
    Shiono A; Kurihara J; Hayashi M; Suzuki T; Imai K; Yamanaka H; Takezawa Y; Kiren H; Okabe K; Tomaru Y
    Hinyokika Kiyo; 1993 Aug; 39(8):777-82. PubMed ID: 8379483
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rational prescribing of extended-spectrum penicillin beta-lactamase inhibitor combinations: focus on ticarcillin/clavulanic acid.
    Reed MD
    Ann Pharmacother; 1998 Jan; 32(1):S17-21. PubMed ID: 9475835
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Timentin and beta-lactamases.
    Labia R; Morand A; Péduzzi J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():17-26. PubMed ID: 3487538
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Detection of hyperproduction of chromosomal beta-lactamase in strains of Escherichia coli, Enterobacter cloacae and Pseudomonas aeruginosa].
    Roy C; Tirado M; Segura C; Esteva C; Teruel D
    Enferm Infecc Microbiol Clin; 1989; 7(6):301-6. PubMed ID: 2518766
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.
    Sanders CC; Iaconis JP; Bodey GP; Samonis G
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1365-9. PubMed ID: 3143303
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bacteriological investigations with beta-lactamase inhibitors.
    Ullmann U
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Timentin (ticarcillin/clavulanic acid): lack of antagonism in an in vitro kinetic model, against bacteria producing inducible class-1 beta-lactamase.
    Slocombe B; Cooper CE; Masters PJ; Warrack JD
    J Chemother; 1989 Jul; 1(4 Suppl):353-4. PubMed ID: 16312436
    [No Abstract]   [Full Text] [Related]  

  • 71. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Penetration of potassium clavulanate/ticarcillin sodium into cerebrospinal fluid in neurosurgical patients].
    Nakagawa H; Yamada M; Tokiyoshi K; Miyawaki Y; Kanayama T
    Jpn J Antibiot; 1994 Jan; 47(1):93-101. PubMed ID: 8114276
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative in-vitro activities of azlocillin, ticarcillin and ticarcillin plus clavulanic acid against Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Lagast H; Husson M; Klastersky J
    J Antimicrob Chemother; 1985 May; 15(5):633-6. PubMed ID: 3924883
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes.
    Fuglesang JE; Bergan T
    Infection; 1983; 11(6):329-35. PubMed ID: 6365790
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1984 Apr; 19(4):555-7. PubMed ID: 6715524
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Antimicrobial activities of major oral antibacterial agents against clinically isolated microbial strains from inpatients].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y
    Jpn J Antibiot; 1992 Aug; 45(8):965-79. PubMed ID: 1433903
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relevant breakpoints for ticarcillin-clavulanic acid should be set primarily with data from ticarcillin-resistant strains.
    Sanders CC; Cavalieri SJ
    J Clin Microbiol; 1990 Apr; 28(4):830-1. PubMed ID: 2332481
    [No Abstract]   [Full Text] [Related]  

  • 78. Detection of ticarcillin-clavulonic acid susceptibility with microdilution method in Citrobacter, Hafnia, Proteus and some gram negative bacteria.
    Uraz G; Oncül O
    Drug Metabol Drug Interact; 2004; 20(3):185-91. PubMed ID: 15508433
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pirbenicillin, a new semisynthetic penicillin with broad-spectrum activity.
    Bodey GP; Rodriguez V; Weaver S
    Antimicrob Agents Chemother; 1976 Apr; 9(4):668-74. PubMed ID: 817665
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study.
    Fuchs PC; Jones RN; Barry AL; Allen SD; Aldridge KE; Gerlach EH; Sommers HM
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):47-50. PubMed ID: 3370931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.